Sector revisions AstraZeneca PLC

Equities

Real-time Estimate Cboe Europe Other stock markets 10:53:51 2025-12-12 am EST			5-day change	1st Jan Change
13,427.00 ^GBX	-1.24%		-1.15%	+28.35%

09:27am	European health regulator recommends approval for GSK's twice-yearly asthma drug	RE
07:06am	Weight-loss drug developers line up to tap lucrative market as competition heats up	RE

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	ASTRAZENECA PLC							19
	ELI LILLY AND COMPANY							27
	JOHNSON & JOHNSON							24
	ABBVIE INC.							29
	ROCHE HOLDING AG							18
	NOVARTIS AG							19
	MERCK & CO., INC.							26
	NOVO NORDISK A/S							20
	AMGEN INC.							27
	GILEAD SCIENCES, INC.							26
	PFIZER INC.							24
	SANOFI							21
	VERTEX PHARMACEUTICALS INCORPORATED							25
	BRISTOL-MYERS SQUIBB COMPANY							22
	GSK PLC							18
	CHUGAI PHARMACEUTICAL CO., LTD.							14
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							18
	ALNYLAM PHARMACEUTICALS, INC.							24
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							14
	Average							22
	Weighted average by Cap.							23